Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day

Journal of the Medical Association of Thailand

Volumn 91, Issue 10, 2008, Pages 1583-1588

  Veerasarn, Vutisiri ^a,c   Boonnuch, Wiroon ^b   Chinswangwatanakul, Vitoon ^b   Lohsiriwat, Darin ^b   Mahamadsolaeh, Pranee ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Capecitabine; Chemoradiation; Radiotherapy; Rectal cancer

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; DYSURIA; FEMALE; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; RADIATION DOSE FRACTIONATION; RECTUM CANCER; SKIN MANIFESTATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PREOPERATIVE CARE; VITAMIN B COMPLEX; YOUNG ADULT;

EID: 55249087415     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sriplung H. Cancer in Thailand. Vol. II, 1992-1994. IARC Technical Report No. 34. Lyon, France: International Agency for Research on Cancer; 1999.
2. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994; 331: 502-7.
3. Dunst J, Reese T, Sutter T, Zuhlke H, Hinke A, Kolling-Schlebusch K, et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 2002; 20: 3983-91.
4. Souglakos J, Androulakis N, Mavroudis D, Kourousis C, Kakolyris S, Vardakis N, et al. Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys 2003; 56: 1284-7.
5. Ngan SY, Michael M, Mackay J, McKendrick J, Leong T, Lim JD, et al. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer 2004; 91: 1019-24.
6. Veerasarn V, Phromratanapongse P, Lorvidhaya V, Lertsanguansinchai P, Lertbutsayanukul C, Panichevaluk A, et al. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). J Med Assoc Thai 2006; 89: 1874-84.
7. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-40.
8. Dunst J, Reese T, Debus J, Hoelscher T, Budach W, Rudat V, et al. Phase-II-study of preoperative chemoradiation with capecitabine in rectal cancer. ASCO Annual Meeting Proceedings (Post-Meeting Edition) J Clin Oncol 2004; 22(14 Suppl): 3559.
9. Kim JC, Kim TW, Kim JH, Yu CS, Kim HC, Chang HM, et al. Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 346-53.
10. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006; 17: 246-51.
11. Kim JS, Kim JS, Cho MJ, Yoon WH, Song KS. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J Korean Med Sci 2006; 21: 52-7.
12. Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002; 13: 566-75.